Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeoTract Inc.

www.neotract.com

Latest From NeoTract Inc.

Teleflex Adds Minimally Invasive BPH System With NeoTract Buy

Teleflex is forking out over $1bn for privately held NeoTract. The latter has seen its revenues grow rapidly due to market enthusiasm for its UroLift system for treating lower urinary tract symptoms related to benign prostatic hyperplasia.

Surgery M & A

New Enterprise Flies Higher

New Enterprise Associates surprised some by locking down $3.1 billion in new capital during a tight fundraising climate. General partner David Mott and partner Justin Klein share the firm’s investment approach.

BioPharmaceutical Medical Device

NICE Guidance: Prostatic Implants, RF Ablation For Snoring, Transcranial Stimulation For Migraine, Arthroscopic Kneecap Surgery

The influential U.K. institute approves the use of prostatic urethral lift implants to treat urinary symptoms in men with benign prostatic hyperplasia, as well as radiofrequency ablation of the soft palate to treat snoring. Transcranial magnetic stimulation for migraine and arthroscopic trochleoplasty to treat patellar instability don’t fare as well.

Medical Device

Regulatory Briefs: Comment Period For Masked Data Release Reopened; Studies On 510(k), Post-Market Programs

FDA has reopened the comment period for its proposal to release masked trial data. The HHS Office of Inspector General released a study on FDA classification of class III pre-amendment devices. More regulatory news.

Medical Device Regulation
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NeoTract Inc.
  • Senior Management
  • David Amerson, Pres. & CEO
    Doug Hughes, CFO
    Joseph Catanese, III, PhD, VP, R&D
    Richard Walsh, VP, International Sales
  • Contact Info
  • NeoTract Inc.
    Phone: (925) 401-0700
    4473 Willow Rd.
    Ste. 100
    Pleasonton, CA 94588
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register